# Myalept

NDC: 10122-210
Generic name: metreleptin
Labeler / Manufacturer: Chiesi USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20150305

FDA application: BLA125390

## Active ingredients

- METRELEPTIN: 11.3 mg/2.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10122-210"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10122-210
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3b50bbd-140b-425c-b5ec-d4682aad62bc